Sae Shimada1, Shintaro Maeda1, Yuki Noguchi1, Shiina Iwai1, Yuta Suzuki1, Hiroshi Sugiyama2, Yasuhiko Kamikubo1, Souichi Adachi1 (1.Human Health Sciences, Kyoto Univ., Kyoto, Japan, 2.Chemistry, Kyoto Univ., Kyoto, Japan)
Session information
Oral Session
Oral Session 1-13D CML: Basic/Clinical
Fri. Oct 12, 2018 4:20 PM - 5:20 PM No.13 (Osaka International Convention Center, 11F 1101-2)
Chair: Hideo Tanaka (Department Hematology& Oncology, Hiroshima City Asa Hospital, Japan)
Takashi Yahata1, Abd Aziz Ibrahim1, Kazuhito Naka2, Toshio Miyata3, Kiyoshi Ando1 (1.Tokai University School of Medicine, Kanagawa, Japan, 2.Hiroshima University, Hiroshima, Japan, 3.Tohoku University, Miyagi, Japan)
Maiko Abumiya1, Akiko Mita2, Tomoko Yoshioka2, Yoshihiro Kameoka2, Naoto Takahashi2, Masatomo Miura1 (1.Pharmacy, Akita Univ. hospital, Japan, 2.Hematology, Nephrology and Rheumatology, Akita Univ., Akita, Japan)
Takeshi Inukai1, Minori Tamai1, Satoru Kojika1, Masako Abe1, Keiko Kagami1, Daisuke Harama1, Tamao Shinohara1, Atsushi Watanabe1, Hiroko Oshiro1, Koshi Akahane1, Kumiko Goi1, Eiji Sugihara2, Shinichiro Nakada3, Kanji Sugita1 (1.Department of Pediatrics, University of Yamanashi, Yamanashi, Japan, 2.Innovation Medical Research Institute, University of Tsukuba, Japan, 3.Department of Bioregulation and Cellular Response, Osaka University, Japan)
Daisuke Koyama, Rie Ito, Koji Umemura, Satomi Yamamoto, Naoto Imoto, Shingo Kurahashi, Isamu Sugiura (Department of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan)
Kan-Ichi Iwama, Yuichi Takeuchi, Marina Matsui, Masao Tukada, Koichi Kajiwara, Kazunari Yamada, Hideki Kodo, Yasuji Kozai (TOKYO METROPOLITAN TAMA MEDICAL CENTER, Tokyo, Jpan)